State Claims Trimmed From AbbVie, Teva Pay-for-Delay MDL
By Allissa Wickham ( September 8, 2014, 8:29 PM EDT) -- A Pennsylvania federal judge on Friday dismissed a slew of state law claims from mulitdistrict litigation against AbbVie Inc. and Teva Pharmaceuticals Industries Ltd. over purported pay-for-delay settlements regarding generics of the cholesterol drug Niaspan but kept the plaintiffs' federal antitrust claims intact....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.